Iron Overload in the Organism as a Health Problem

Polish Journal of Environmental Studies

Volumn 8, Issue 1, 1999, Pages 1-5

  Szatko, F ^a   Paradowska Stankiewicz, I ^a   Grzybowski, A ^a  

^a NONE

Author keywords

Genetic conditioning; Haemochromatosis; Iron overload

Indexed keywords

EID: 0348224175     PISSN: 12301485     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. ADANS P.C., DEUGNIER Y., MOIRAND R., BRISSOT P. The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis. Hepatology, 25 (1), 161,1997.
2. BACON B., BRITTON R. The pathology of hepatic iron overload: a free radical - mediated process? Hepat. 1, 127, 1990.
3. NASKALSKI J.W. Badanie i diagnoza. Nowości diagnostyki laboratoryjnej.1 (2), 9, 1995.
4. BARISANI D., GREEN R.M., GOLLAN J.L. Genetic hemochromatosis: pathogenesis, diagnosis, and therapy. Dig-Dis. 14 (5), 304, 1996.
5. BEARD J. One person's view of iron deficiency, development, and cognitive function. Am. J. Clin. Nutr. 62, 709, 1995.
6. BONKOVSKY H.L. et al. An update on iron metabolism: of summary the Fifth International Conference on Disorders of Iron Metabolism. Hepatology, 24 (3), 718, 1996.
7. BORG D., SCHAICH K. Fenton reactions in lipid phases: iron solubility. OH production, and initiation of lipid oxidation. Basic-Life-Sci. 49 153, 1988.
8. BOTHWELL T., CHARITON R. Iron deficiency in women. Raport The International Nutritional Anemia Consultative Group University of the Witwatersrand Johannesburg 1981.
9. BRITTON R., BACON B., RECKNAGEL R. Lipid Peroxidation and Associated Hepatic Organelle Dysfunction in Iron Overload. Chem. Phys. Lip., 45, 207, 1987.
10. BRUHL W., BROZOWSKI R. Vademecum lekarza ogólnego. PZWL, Warszawa 1990.
11. CHAPMAN R.W, MORGAN M. Y, BOSS A.M, SHERLOCK S. Acute and chronic effects of alcohol on iron absorption. Dig. Dis. Sci. 28, 321, 1983.
12. CHASE M.C., RIEDINGER D. Neonatal hemochromatosis: a case raport. Neonatal-Netw. 14 (7), 7, 1995.
13. CONRAD M.E. et al. Hereditary hemochromatosis: a prevalent disorder of iron metabolism with an elusive etiology. Am. J. Hematol. 47 (3), 218, 1994.
14. DALLMAN P. R. Iron deficiency: does it matter? J. Intern Med. 226, 367, 1989.
15. DINNEEN S.F et al. Serum ferritin in newly diagnosed and poorly controlled diabetes mellitus. Ir. J. Med. Sci. 161, 636, 1992.
16. DORAK M.T., BURNETT A.K., WORWOOD M. Thymus-leukaemia antigens: the hemochromatosis gene product? Immunol-Cell-Biol. 72 (5), 435, 1994.
17. FAIRBANKS V.F: Laboratory testing for iron status. Hosp Pract. (Off Ed), 3, suppl. 23, 17, 1991.
18. FLEXNER J. M. Hemochromatosis: diagnosis and treatment. Compr-Ther. 17 (11), 7, 1991.
19. GERLACH D., BEN-SHACHAR P., RIEDERER P., YOUDIM M.B.H. Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases? Journal of Neurochemistry, 63, (3), 993, 1994.
20. GORDEUK V., BACON B., BRITTENHAM G. Iron overload: causes and consequences.Ann. Rev. Nutr. 7, 485, 1987.
21. GRONBAEK K.E. et al. Preclinical hereditary hemochromatosis - is there an indication for preventive screening? Ugeskr-Laeger. 157 (30), 4249, 1995.
22. HALLIDAY J.W, POWELL L.W. Iron overolad. Semin. Hematol. 19, 42, 1982.
23. JACOBS A. Disorders of iron metabolism. Rec. Adv. Haem. 3, 11, 1982.
24. JAULMES D. et al. Post - transfusion hemochromatosis. Results of a study carried out in Blood Transfusion Centers. Analysis of 15 cases treated with subcutaneous perfusion of Desferal. Working group "Transfusion Techniques and Therapeutics". Transfus-Clin-Biol. 1 (3), 258, 1994.
25. KARWATOWSKA-PROKOPCZUK Ł., CZARNOWSKA E., BARESZWICZ A. Iron availability and free radical induced injury in isolated reperfused rat heart. Cardiovasc. Res., 26 (1), 58, 1992.
26. KIRKING M.H. Treatment of chronic iron overload. Clin-Pharm. 10 (10), 775, 1991.
27. LE-GALL J.Y. et al. Molecular genetics of hemochromatosis. Ann-Gastroenterol-Hepatol. Paris, 29 (6), 292, 1993.
28. LAUFFER R. Iron stores and the international variation in mortality from coronary artery disease. Med. Hyp. 38, 96, 1990.
29. LESNEFSKY E.J. Tissue iron overload and mechanism of iron catalyzed oxidative injury. Adv.-Exp-Med-Biol. 366, 129, 1994.
30. MAC DONALD R. A., BAUMSLAG N. Iron in alcoholic beverages. Possible significance for hemochromatosis. Am. J. Med. Sci. 247, 649, 1964.
31. MARKS P.W., MITUS A.J. Congenital dyscrythropoietic anemias. Am. J. Hematol. 51 (1), 51, 1996.
32. MAZZANTI R.: The effect of chronic ethanol consumption on iron absorption in rats. Alc. Alcoholism., 22 (1), 47, 1987.
33. MEYER T.E., KASSIANIDES C., BOTHWELL T.H., GREEN A. Effects of heavy alcohol consumption on serum ferritin concentrations. S Afr. Med. J. 66, 573, 1984.
34. MOUSSA B., YOUDIM M., RIEDERER P. Zrozumieć chorobe Parkinsona. Świat Nauki, 1997.
35. NOVIKOV S.A Hemochromatosis in a newborn. Atkh-Patol. 55 (4), 78, 1993.
36. OLYNYK J.K., BACON B. R. Hereditary hemochromatosis. Detecting and correcting iron overload. Postgrad-Med. 96 (5), 151-8, 161, 165, 1994.
37. RAFALSKI H., PONOMARENKO W., SZYLER I. Effects of iron fortified bread roll on hematological indices and clinical symptoms in menstruating women. Human Nutrition, 33, 1-2, 53-58, 1982.
38. RAFALSKI H., BERNACKI K., KE + (combining ogonek)SY-DA + (combining ogonek)BROWSKA I., PONOMARENKO W., ŚWITONIAK T. Iron deficiency in Poland -Call For Mass Prevention. Żywienie Człowieka i Metabolizm, 15 (4), 304, 1988.
39. RELIGA H., SPLIT W. Hemochromatoza samoistna z zajc + (combining ogonek)ciem układu nerwowego. Wiad. Lek., 24 (12), 1191, 1971.
40. SALONEN J.T. The role of iron as cardiovascular risk factor. Current opinion in lipidology. 4, 277, 1993.
41. SALONEN J. T. et al. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation, 86, 803, 1992.
42. SCIMECA P.G. et al. Does rapidly progressive iron overload in a young girl with sideroblastic anemia also signify the presence of hereditary hemochromatosis? Pediatr-Hematol-Oncol. 11 (1), 99, 1994.
43. SHIMIZU M., ISOGAI Y. Heart failure due to metabolic heart disorders. Nippon-Rinsho. 51 (5), 1362, 1993.
44. SKŁODOWSKA M.: Antyoksydacyjna obrona organizmu na podstawie enzymatycznych i nieenzymatycznych składników krwi. Badania epidemiologiczne regionu Łódzkiego. Wydawnictwo Uniwersytetu Łódzkiego, Łódź, 27-29, 1997.
45. SPRAUL C. W. et al. Ocular side effects of deferoxamine therapy in aplastic anemia with transfusion-induced hemochromatosis. Klin-Monatsbl-Augenheilkd. 209 (1), 31, 1996.
46. STEVENS R.G, JONES D.Y., MICOSSI M.S., TAYLOR P.R. Body iron stores and the risk of cancer. N. Engl. J. Med., 319, 1047, 1988.
47. STEVENS R., KALKWARF D. Iron radiation and cancer. Environ. Health Persp. 87, 291, 1990.
48. STREMMEL W. et al. Pathogenesis of genetics hemochromatosis. Eur. J. Clin. Invest. 23 (6), 321, 1993.
49. SULLIVAN J.L. The iron paradigm of ischaemic heart disease. Am. Heart J. 117, 1177, 1989.
50. SULLIVAN J.L. Iron and the sex difference in heart disease risk. Lanc. 6, 1293, 1981.
51. TE + (combining ogonek)GOWSKA E. Rola żelaza w procesach immunologicznych. Post. Hig. Med. Dośw. 46 (4), 361, 1992.
52. WEINBERK E. Iron infection and neoplasia. Clin. Physiol. Bioch. 4, 5022, 1986.
53. WITTE D.L. et al. Practice guideline development task force of the College of American Pathologist. Hereditary hemochromatosis. Clin-Chim-Acta. 245 (2), 139, 1996.
54. VAN-LINTHOUD D., SO A.K. Miscellaneous metabolic disease [see comments]. Curr-Opin-Rheumatol. 8 (3), 262, 1996.
55. YAOUANQ J.M. Diabetes and hemochromatosis: current concepts, management and prevention. Diabete-Metab. 21 (5), 319, 1995.
56. YOUDIM M., BEN-SHACHER D., RIEDRER P. Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration? Act. Neurol. Scand. 126, 47, 1989.